Applications of Pharmacogenomics in Precision Medicine
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 40
Special Issue Editors
Interests: personalized medicine; pharmacogenomics; evolutionary biology; population genetics; public health genomics
Interests: pharmacogenomics/pharmacotranscriptomics in various diseases (pediatric acute lymphoblastic leukemia, inflammatory bowel disease, COVID-19); population pharmacogenomics; personalized medicine; molecular basis of personalized treatment of solid tumors (non-small cell lung carcinoma, hepatocellular carcinoma)
Interests: pharmacogenomics; personalized medicine; ancestry; ethnic groups
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pharmacogenomics is a growing backbone of personalized medicine, reshaping drug therapy by accounting for individual genetic variation. With advances in genomic technologies and bioinformatics, clinicians can now better predict drug response, minimize or even prevent adverse drug reactions, and select the most effective treatments tailored to each patient’s genetic profile.
This Special Issue will explore the translational and clinical applications of pharmacogenomics across a broad spectrum of medical fields, including cardiology, psychiatry, oncology, infectious diseases, rare disorders, and beyond. We invite original research articles, reviews, case studies, and methodological papers that examine key areas such as the detection and characterization of novel or known pharmacogenomic variants, their interaction with other drugs (drug–gene interactions), clinical implementation strategies, pharmacogenomics across admixed populations, regulatory frameworks, and ethical considerations.
Particular interest will be given to submissions focused on drug–gene interactions, pharmacogenomic biomarkers, multi-omics integration, and the role of pharmacogenomics in addressing health disparities and advancing precision therapeutics.
By bringing together insights from academia, clinical practice, and industry, this Special Issue aims to highlight the current landscape, innovations, and practical challenges in applying pharmacogenomics to achieve safer, more effective, and individualized patient care.
Dr. Kariofyllis Karamperis
Dr. Branka Zukic
Dr. Fernanda Rodrigues-Soares
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized medicine
- pharmacogenomics
- drug–gene interactions
- adverse drug reactions
- pharmacogenomic biomarkers
- multi-omics
- population pharmacogenomics
- precision therapeutics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
